T‐cell responses and therapies against SARS‐CoV‐2 infection
<p>Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, a novel coronavirus strain. Some studies suggest that COVID-19 could be an immune-related disease, and failure of effective immune responses in initial stages of viral infection could contribute to systemic inflammation and tissue...
Saved in:
| Main Author: | Salman M. Toor (8854751) (author) |
|---|---|
| Other Authors: | Reem Saleh (3513056) (author), Varun Sasidharan Nair (5396393) (author), Rowaida Z. Taha (8854754) (author), Eyad Elkord (5396390) (author) |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants
by: Hebah A., Al-Khatib
Published: (2022) -
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
by: Ridhima Kaul (12485902)
Published: (2021) -
Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020
by: Houssein H., Ayoub
Published: (2021) -
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
by: Queenie Fernandes (14557388)
Published: (2022) -
SARS-CoV-2 Infection and Smoking: What is the association? A brief review
by: Ishita, Gupta
Published: (2021)